Opportunity timeline

PostedOct 22, 2026
DeadlineOct 30, 2026

In plain English

The VA plans to award Natera a sole-source contract for molecular laboratory tests used to monitor transplant patients and cancer residual disease. Estimated quantities are 35 Signatera tests and 25 Prospera tests for VA facilities in Texas, across five ordering periods. This is not a request for quotes; companies claiming they can provide an equivalent test may email a capability statement by November 2, 2026, at 10:00 a.m. CST.

About this opportunity

Special Notice Special Notice Page 3 of 3 Special Notice *= Required Field Special Notice Page 1 of 3

1. NOTICE OF INTENT DESCRIPTION

The Department of Veterans Affairs, Network Contracting Office (NCO) 17, located at 5441 Babcock Road, Suite 302, San Antonio, TX 78229, intends to award an Indefinite Delivery Indefinite Quantity (IDIQ) Firm Fixed Price contract with five ordering periods on a sole-source basis to: Natera, Inc. 13011 McCallen Pass Austin, TX 78752 This requirement is for proprietary molecular genetic reference testing services used in the evaluation and monitoring of transplant patients and cancer residual disease.

2. SUPPLIES/SERVICES

Time remaining

Closes Oct 30, 2026

01Days
:
09Hours
:
51Min
:
56Sec

Related Opportunities

Bid details are gathered and summarized automatically. Please verify details at the original source.

Ref No.

BS-CC20E0